Literature DB >> 22986800

Relief of intractable posthypoxic myoclonus after administration of agomelatine.

Jesús González de la Aleja1, Rosa Ana Saiz-Díaz, Pilar De la Peña.   

Abstract

Chronic posthypoxic myoclonus is characterized by myoclonic jerks that are specifically triggered by action. It is a rare but devastating sequela of hypoxic encephalopathy. We report a 42-year-old female patient with treatment-resistant chronic posthypoxic myoclonus, which improved with administration of the drug agomelatine. We suggest that agomelatine could represent a useful therapeutic option in the treatment of chronic posthypoxic myoclonus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22986800     DOI: 10.1097/WNF.0b013e3182613e06

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  3 in total

Review 1.  Physiology-Based Treatment of Myoclonus.

Authors:  Ashley B Pena; John N Caviness
Journal:  Neurotherapeutics       Date:  2020-10       Impact factor: 7.620

Review 2.  Post-hypoxic Myoclonus: Current Concepts, Neurophysiology, and Treatment.

Authors:  Harsh V Gupta; John N Caviness
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-09-17

3.  Increasing Evidence for the Use of Sodium Oxybate in Multi-Drug-Resistant Lance-Adams Syndrome.

Authors:  Giulietta M Riboldi; Steven J Frucht
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2019-06-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.